NL128191C - - Google Patents

Info

Publication number
NL128191C
NL128191C NL128191DA NL128191C NL 128191 C NL128191 C NL 128191C NL 128191D A NL128191D A NL 128191DA NL 128191 C NL128191 C NL 128191C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL128191C publication Critical patent/NL128191C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL128191D 1965-01-12 NL128191C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH41465A CH458365A (de) 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten

Publications (1)

Publication Number Publication Date
NL128191C true NL128191C (fr)

Family

ID=4186481

Family Applications (2)

Application Number Title Priority Date Filing Date
NL128191D NL128191C (fr) 1965-01-12
NL6600250A NL6600250A (fr) 1965-01-12 1966-01-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6600250A NL6600250A (fr) 1965-01-12 1966-01-10

Country Status (11)

Country Link
US (1) US3350400A (fr)
BE (1) BE674919A (fr)
BR (1) BR6676358D0 (fr)
CH (1) CH458365A (fr)
DE (1) DE1545772B1 (fr)
DK (1) DK114482B (fr)
ES (1) ES321531A1 (fr)
FR (2) FR1463438A (fr)
GB (1) GB1084150A (fr)
IT (1) IT7830644A0 (fr)
NL (2) NL6600250A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
WO2020150473A2 (fr) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3032554A (en) * 1962-05-01 Process for the preparation of new
DE1011424B (de) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen
US3029239A (en) * 1954-04-17 1962-04-10 Chemiewerk Homburg Zweignieder Basic substituted 1-and 7-alkylxanthines or salts thereof
DE1018869B (de) * 1954-12-14 1957-11-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Aminoalkylpurinderivaten
DE1112983B (de) * 1958-11-21 1961-08-24 Sandoz Ag Verfahren zur Herstellung von Theophyllin-Derivaten
CH402872A (de) * 1959-12-18 1965-11-30 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von Theophyllin- oder Theobromin-Derivaten

Also Published As

Publication number Publication date
DK114482B (da) 1969-07-07
NL6600250A (fr) 1966-07-13
ES321531A1 (es) 1966-11-01
FR5128M (fr) 1967-06-05
CH458365A (de) 1968-08-30
BE674919A (fr) 1966-07-11
FR1463438A (fr) 1966-12-23
US3350400A (en) 1967-10-31
BR6676358D0 (pt) 1973-09-06
IT7830644A0 (it) 1978-12-06
GB1084150A (fr)
DE1545772B1 (de) 1969-12-11

Similar Documents

Publication Publication Date Title
FR5128M (fr)
JPS4215613Y1 (fr)
FI42613B (fr)
JPS4322545Y1 (fr)
JPS4322385Y1 (fr)
JPS422895Y1 (fr)
JPS4211452Y1 (fr)
BE675253A (fr)
BE675209A (fr)
BE665425A (fr)
BE673686A (fr)
NL6605806A (fr)
NL6602901A (fr)
BE664337A (fr)
NL6601666A (fr)
NL6600209A (fr)
BE665442A (fr)
BE690296A (fr)
BE677904A (fr)
BE675274A (fr)
BE675273A (fr)
BE674914A (fr)
BE675251A (fr)
BE675243A (fr)
BE675212A (fr)